JAMA dermatology
Non-Randomized Controlled Trial
Oral PCS499 Improves Skin Activity and Ulcer Healing in Necrobiosis Lipoidica
A phase 2 trial of a deuterated pentoxifylline analog shows 50% of patients achieved clear or almost clear status with no serious safety concerns.
JAMA Dermatology
Diagnostic Accuracy Study
Imaging Accurately Stages Nodal Squamous Cell Carcinoma Except in Immunosuppression
Ultrasonography and CT show 100% sensitivity in immunocompetent patients but fail to detect most early metastases in the immunosuppressed.